20/20 OptimEyes Technologies
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
20/20 OptimEyes Technologies offers a mucoadhesive drug delivery platform enhancing API solubility and extended release. Validated for eye drops in a pre-clinical glaucoma program, we seek investments and partnerships for mucosal-targeted therapies.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}